ALNY vs VSTM · P/E 76, rev $1.29B vs rev $58.7M
Alnylam Pharmaceuticals Inc (ALNY) versus Verastem Inc (VSTM) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Verastem Inc (VSTM) is a biotechnology company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported VSTM revenue for 2026-06-30 was $58.7M. Net income was -$71.3M. VSTM currently screens at market cap $264.3M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. VSTM currently screens at market cap $264.3M.
Not investment advice. Open the ALNY and VSTM stock pages for the full models.
Not investment advice.